Connecticut will receive $6 million as part of a massive $1.5 billion civil and criminal health care fraud settlement between a large pharmaceutical company and federal and state governments over allegations the company promoted a drug for unauthorized uses.
Specifically, according to state Attorney General George Jepsen, Illinois-based Abbott Laboratories promoted the sale and use of the prescription drug Depakote for uses that were not approved by the U.S. Food and Drug Administration (FDA) as safe and effective.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
